Navigation Links
Advancing Preclinical Predictions, Making Faster Clinical Decisions with Cancer Models and Preclinical Imaging - World Pharma Congress this June in Philadelphia
Date:5/15/2013

FARMINGTON, Conn., May 15, 2013 /PRNewswire-iReach/ -- World Pharma Congress is celebrating 12 years of preclinical research with its annual event covering the latest in drug targets, high-throughput screening, lead optimization, ADME and drug safety. Years of effectively covering the latest preclinical strategies and technologies that drive better predictions has culminated in priming this year's event to move further downstream into early formulations and drug delivery.

(Photo: http://photos.prnewswire.com/prnh/20130515/CG14746)

Why Attend?

Preclinical efforts targeted towards discovery, screening, safety and drug delivery

Active brainstorming and networking opportunity for experts from industry and academia Interactive pre-conference short courses taught by experts in an informal setting

Updates from leading technology and service providers on the latest tools and services

Informative roundtables, panels, posters, stimulating communication and collaboration

For further featured conference programs, please visit links below:

Predictive Preclinical Models in Oncology

Pain Therapeutics

Drug Delivery and Formulation

Predicting Drug-Induced Organ Toxicities Using Functional Assays, Models and Markers

Integrating Molecular Imaging Technologies to Improve Preclinical Findings

Easy conference registration is available through Global Information's online registration system at https://www.giiresearch.com/conference/en/order/253345

Event Organizers: Need to reach biotech, pharmaceutical, and healthcare executives in Asia?

For over a decade, Global Information Inc, through our GlobalReach event service, has connected conference and event organizers in the West with attendees, exhibitors, and sponsors in the East. Offering affordable fixed-price translation, localization, and conference marketing services, GlobalReach bridges the gap between cultures to connect organizers with the fastest growing markets on the planet. Visit our website or contact us today to learn more.

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 400 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 30 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Joe Malley Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. 4th Annual Advancing Global Clinical Trials Conference is Announced
2. Astute Medical, Inc. Advancing Next Generation Acute Kidney Injury Biomarkers
3. CureLauncher is Described on LIVESTRONG Blog as Modern Platform That Gets People Involved in Advancing New Cancer Treatments
4. GenoSpace Announces the Launch of a Cloud-Based "Information Ecosystem" for Advancing 21st-Century Personalized Medicine
5. Preclinical study shows heroin vaccine blocks relapse
6. Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2013 Edition
7. arGEN-X advances ARGX-113 into preclinical development for autoimmune disorders
8. Translating Preclinical Pharmacology to Clinical Activity with Myriad RBM’s Inflammation MAP
9. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
10. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
11. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
Breaking Biology Technology:
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):